Previous Close | 4.1300 |
Open | 4.1600 |
Bid | 0.0000 x 900 |
Ask | 0.0000 x 800 |
Day's Range | 4.0000 - 4.3000 |
52 Week Range | 0.3600 - 6.0400 |
Volume | |
Avg. Volume | 592,550 |
Market Cap | 393.564M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ADC Therapeutics ( NYSE:ADCT ) First Quarter 2024 Results Key Financial Results Revenue: US$18.1m (down 4.9% from 1Q...
On May 7, 2024, Ameet Mallik, Chief Executive Officer of ADC Therapeutics SA (NYSE:ADCT), sold 29,731 shares of the company.
Last week, you might have seen that ADC Therapeutics SA ( NYSE:ADCT ) released its quarterly result to the market. The...